Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 93,000 CLDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 93,000 | n/a |
| Jan 6, 2026 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 4,817 | $50.0K |
| Jun 9, 2025 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 81,000 | n/a |
| Jun 18, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 3,201 | $28.9K |
| Jun 17, 2024 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 81,000 | n/a |
| Jun 3, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 25,000 | $259.5K |
| Jan 4, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 10,750 | $29.9K |
| Jun 20, 2023 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 80,000 | n/a |
| Aug 15, 2022 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 2,453 | $22.1K |
| Jun 17, 2022 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 85,000 | n/a |